Press
Releases

July 8, 2025 Jade Biosciences to Participate in Two Upcoming Investor Conferences July 1, 2025 Jade Biosciences Appoints Brad Dahms as Chief Financial Officer June 9, 2025 Jade Biosciences Presents JADE101 Preclinical Data at the 62nd European Renal Association Congress Demonstrating Potential for Best-in-Class Profile in IgA Nephropathy June 2, 2025 Jade Biosciences to Present New Preclinical Data on JADE101 at the 62nd European Renal Association Congress May 14, 2025 Jade Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Update May 13, 2025 Jade Biosciences to Participate in the 2025 Jefferies Global Healthcare Conference April 28, 2025 Jade Biosciences Completes Closing of Merger with Aerovate Therapeutics and Previously Announced Private Placement of Approximately $300 Million  February 12, 2025 Jade Biosciences to Participate in TD Cowen’s 45th Annual Health Care Conference and Jefferies Biotech on the Beach Summit November 13, 2024 Jade Biosciences to Participate in Upcoming Investor Conferences October 31, 2024 Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement